Métadonnées
Afficher la notice complètePartager cette publication !
The menace of obesity to depression and anxiety prevalence
Langue
EN
Article de revue
Ce document a été publié dans
Trends in Endocrinology and Metabolism. 2022-01, vol. 33, n° 1, p. 18-35
Résumé en anglais
The incidence of depression and anxiety is amplified by obesity. Mounting evidence reveals that the psychiatric consequences of obesity stem from poor diet, inactivity, and visceral adipose accumulation. Resulting metabolic ...Lire la suite >
The incidence of depression and anxiety is amplified by obesity. Mounting evidence reveals that the psychiatric consequences of obesity stem from poor diet, inactivity, and visceral adipose accumulation. Resulting metabolic and vascular dysfunction, including inflammation, insulin and leptin resistance, and hypertension, have emerged as key risks to depression and anxiety development. Recent research advancements are exposing the important contribution of these different corollaries of obesity and their impact on neuroimmune status and the neural circuits controlling mood and emotional states. Along these lines, this review connects the clinical manifestations of depression and anxiety in obesity to our current understanding of the origins and biology of immunometabolic threats to central nervous system function and behavior. © 2021 The Authors< Réduire
Mots clés en anglais
Adiposity
Nutrition
Stress
Mood disorder
Neuroinflammation
Neuroplasticity
Unités de recherche